Association of Helicobacter pylori infection with hepatic encephalopathy risk: A systematic review

Clinics and Research in Hepatology and Gastroenterology

Volumn 37, Issue 6, 2013, Pages 619-625

  Hu, Bang Li ^a   Wang, Hong Yu ^a   Yang, Guang Ye ^a  

^a Guangxi Medical Information Institute   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIA;

AMMONIA BLOOD LEVEL; ARTICLE; DISEASE ASSOCIATION; DISEASE ERADICATION; HELICOBACTER INFECTION; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER CIRRHOSIS; RISK ASSESSMENT; SYSTEMATIC REVIEW;

AMMONIA; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HEPATIC ENCEPHALOPATHY; HUMANS; LIVER CIRRHOSIS; PREVALENCE; RISK ASSESSMENT; STOMACH;

EID: 84888435177     PISSN: 22107401     EISSN: 2210741X     Source Type: Journal    
DOI: 10.1016/j.clinre.2013.05.004     Document Type: Article

References (36)

1. Amodio P., Montagnese S., Gatta A., Morgan M.Y. Characteristics of minimal hepatic encephalopathy. Metab Brain Dis 2004, 19:253-267.
2. Riordan S.M., Williams R. Treatment of hepatic encephalopathy. N Engl J Med 1997, 337:473-479.
3. Demirturk L., Yazgan Y., zci O., Ozel M., Togrol E., Gultepe M., et al. The effect of Helicobacter pylori eradication on gastric juice and blood ammonia concentrations and on visual evoked potentials in cirrhotics. Helicobacter 2001, 6:325-330.
4. Queiroz D.M., Rocha A.M., Rocha G.A., Cinque S.M., Oliveira A.G., Godoy A., et al. Association between Helicobacter pylori infection and cirrhosis in patients with chronic hepatitis C virus. Dig Dis Sci 2006, 51:370-373.
5. Shimamoto C., Hirata I., Katsu K. Breath and blood ammonia in liver cirrhosis. Hepatogastroenterology 2000, 47:443-445.
6. Nandakumar R., Naik A.S., Pandit B., Kamat R., Bhatia S.J. Effect of Helicobacter pylori eradication on serum ammonia levels in patients with chronic liver disease. Indian J Gastroenterol 2003, 22:221-223.
7. Miquel J., Barcena R., Boixeda D., Fernandez J., SanRoman A.L., Martin-de-Argila C., et al. Role of Helicobacter pylori infection and its eradication in patients with subclinical hepatic encephalopathy. Eur J Gastroenterol Hepatol 2001, 13:1067-1072.
8. Huber M., Rossle M., Siegerstetter V., Ochs A., Haag K., Kist M., et al. Helicobacter pylori infection does not correlate with plasma ammonia concentration and hepatic encephalopathy in patients with cirrhosis. Hepatogastroenterology 2001, 48:541-544.
9. Miyaji H., Ito S., Azuma T., Ito Y., Yamazaki Y., Ohtaki Y., et al. Effects of Helicobacter pylori eradication therapy on hyperammonaemia in patients with liver cirrhosis. Gut 1997, 40:726-730.
10. Zullo A., Rinaldi V., Meddi P., Hassan C., Winn S., Attili A.F. Helicobacter pylori infection, plasma ammonia levels, and psychometric testing in cirrhotic patients. Am J Gastroenterol 1999, 94:2214-2218.
11. Zullo A., Hassan C., Morini S. Hepatic encephalopathy and Helicobacter pylori: a critical reappraisal. J Clin Gastroenterol 2003, 37:164-168.
12. Ross L.E., Grigoriadis S., Mamisashvili L., Koren G., Steiner M., Dennis C.L., et al. Quality assessment of observational studies in psychiatry: an example from perinatal psychiatric research. Int J Methods Psychiatr Res 2011, 20:224-234.
13. Scotiniotis I.A., Lucey M.R., Metz D.C. Helicobacter pylori infection is not associated with subclinical hepatic encephalopathy in stable cirrhotic patients. Dig Dis Sci 2001, 46:2744-2751.
14. Kini D., Aggarwal R., Saraswat V.A., Naik S.R. Role of Helicobacter pylori infection in hyperammonemia and subclinical hepatic encephalopathy in cirrhosis of liver. Indian J Gastroenterol 2001, 20:237-240.
15. Gubbins G.P., Moritz T.E., Marsano L.S., Talwalkar R., McClain C.J., Mendenhall C.L. Helicobacter pylori is a risk factor for hepatic encephalopathy in acute alcoholic hepatitis: the ammonia hypothesis revisited. The Veterans Administration Cooperative Study Group No.275. Am J Gastroenterol 1993, 88:1906-1910.
16. Dasani B.M., Sigal S.H., Lieber C.S. Analysis of risk factors for chronic hepatic encephalopathy: the role of Helicobacter pylori infection. Am J Gastroenterol 1998, 93:726-731.
17. Chen S.J., Wang L.J., Zhu Q., Cai J.T., Chen T., Si J.M. Effect of H.pylori infection and its eradication on hyperammo-nemia and hepatic encephalopathy in cirrhotic patients. World J Gastroenterol 2008, 14:1914-1918.
18. Chakrabarti P., Zullo A., Hassan C., Pandit A., Chowdhury A., Santra A., et al. Helicobacter pylori, gastric juice, and arterial ammonia levels in patients with cirrhosis. J Clin Gastroenterol 2002, 34:578-581.
19. Calvet X., Nogueras C., Roque M., Sanfeliu I. Helicobacter pylori is not a risk factor for hepatic encephalopathy. Dig Liver Dis 2001, 33:414-419.
20. Agrawal A., Gupta A., Chandra M., Koowar S. Role of Helicobacter pylori infection in the pathogenesis of minimal hepatic encephalopathy and effect of its eradication. Indian J Gastroenterol 2011, 30:29-32.
21. Abdel-Hady H., Zaki A., Badra G., Lotfy M., Selmi C., Giorgini A., et al. Helicobacter pylori infection in hepatic encephalopathy: relationship to plasma endotoxins and blood ammonia. Hepatol Res 2007, 37:1026-1033.
22. Yang C.S., Cao S.Y., He X.J., Wang Y.X., Zhang Y.L. [Study of correlation between Helicobacter pylori infection and hyperammonemia and hepatic encephalopathy in cirrhotic patients]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2007, 19:422-424.
23. Nam Y.J., Kim S.J., Shin W.C., Lee J.H., Choi W.C., Kim K.Y., et al. [Gastric pH and Helicobacter pylori infection in patients with liver cirrhosis]. Korean J Hepatol 2004, 10:216-222.
24. Sethar G.H., Ahmed R., Zuberi B.F., Afsar S. Frequency of Helicobacter pylori antibodies in porto-systemic encephalopathy. J Coll Physicians Surg Pak 2004, 14:530-533.
25. Vasconez C., Elizalde J.I., Llach J., Gines A., de la Rosa C., Fernandez R.M., et al. Helicobacter pylori, hyperammonemia and subclinical portosystemic encephalopathy: effects of eradication. J Hepatol 1999, 30:260-264.
26. Shavakhi A., Shariatifar B., Chuloo S.A., Minakari M., Somi M.H. Effect of Helicobacter pylori eradication on hepatic encephalopathy. Hepat Mon 2008, 8:121-124.
27. Shrimali L., Chadda V.S., Singh V.B., Soni P.K., Nayak K.C., Gupta B.K. Study of prevalence of H.pylori in hepatic encephalopathy due to various liver diseases. Indian Acad Clin Med 2001, 2:195-197.
28. Rekha C., Phanidhar S., Sagar A.V., Revathi A., Asra W.A. Role of Helicobacter pylori and hyperammonemia in subclinical hepatic encephalopathy in cirrhosis of liver. Indian J Clin Biochem 2007, 22:136-139.
29. Nardone G., Coscione P., D'Armiento F.P., Del Pezzo M., Pontillo M., Mossetti G., et al. Cirrhosis negatively affects the efficiency of serologic diagnosis of Helicobacter pylori infection. Ital J Gastroenterol 1996, 28:332-336.
30. Taylor-Robinson S.D., Jackson N., Buckley C. Helicobacter pylori, ammonia and the brain. Gut 1997, 40:805-806.
31. Riggio O., Ariosto F., Merli M., Caschera M., Zullo A., Balducci G., et al. Short-term oral zinc supplementation does not improve chronic hepatic encephalopathy. Results of a double-blind crossover trial. Dig Dis Sci 1991, 36:1204-1208.
32. Riggio O., Merli M., Capocaccia L., Caschera M., Zullo A., Pinto G., et al. Zinc supplementation reduces blood ammonia and increases liver ornithine transcarbamylase activity in experimental cirrhosis. Hepatology 1992, 16:785-789.
33. Dunn B.E., Campbell G.P., Perez-Perez G.I., Blaser M.J. Purification and characterization of urease from Helicobacter pylori. J Biol Chem 1990, 265:9464-9469.
34. Turbett G.R., Nandapalan N., Campbell I.G., Nikoletti S.M., Mee B.J. Characterisation of the urease from Helicobacter pylori and comparison with the ureases from related spiral gastric bacteria. FEMS Microbiol Immunol 1991, 3:19-24.
35. Vilstrup H. Cirrhosis and bacterial infections. Rom J Gastroenterol 2003, 12:297-302.
36. Ponzetto A., Fagoonee S., Pellicano R. Helicobacter pylori and liver: an actor with three roles. Dig Liver Dis 2001, 33:399-401.